Logo image of RAY

RAYTECH HOLDING LTD (RAY) Stock Fundamental Analysis

USA - NASDAQ:RAY - VGG7385S1011 - Common Stock

0.57 USD
+0.03 (+5.95%)
Last: 9/15/2025, 8:00:01 PM
0.58 USD
+0.01 (+1.75%)
After Hours: 9/15/2025, 8:00:01 PM
Fundamental Rating

6

Taking everything into account, RAY scores 6 out of 10 in our fundamental rating. RAY was compared to 22 industry peers in the Distributors industry. RAY gets an excellent profitability rating and is at the same time showing great financial health properties. RAY has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year RAY was profitable.
In the past year RAY had a positive cash flow from operations.
In the past 5 years RAY has always been profitable.
RAY had a positive operating cash flow in each of the past 5 years.
RAY Yearly Net Income VS EBIT VS OCF VS FCFRAY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 2025 5M 10M 15M

1.2 Ratios

RAY's Return On Assets of 13.62% is amongst the best of the industry. RAY outperforms 90.91% of its industry peers.
Looking at the Return On Equity, with a value of 16.79%, RAY is in the better half of the industry, outperforming 72.73% of the companies in the same industry.
RAY has a Return On Invested Capital of 11.76%. This is in the better half of the industry: RAY outperforms 77.27% of its industry peers.
The Average Return On Invested Capital over the past 3 years for RAY is significantly above the industry average of 15.24%.
The last Return On Invested Capital (11.76%) for RAY is well below the 3 year average (21.00%), which needs to be investigated, but indicates that RAY had better years and this may not be a problem.
Industry RankSector Rank
ROA 13.62%
ROE 16.79%
ROIC 11.76%
ROA(3y)14.95%
ROA(5y)27.53%
ROE(3y)24.16%
ROE(5y)43.37%
ROIC(3y)21%
ROIC(5y)38.94%
RAY Yearly ROA, ROE, ROICRAY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 2025 20 40 60 80

1.3 Margins

RAY has a better Profit Margin (10.59%) than 95.45% of its industry peers.
In the last couple of years the Profit Margin of RAY has declined.
The Operating Margin of RAY (9.48%) is better than 81.82% of its industry peers.
RAY's Operating Margin has declined in the last couple of years.
RAY has a Gross Margin of 22.10%. This is comparable to the rest of the industry: RAY outperforms 50.00% of its industry peers.
RAY's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 9.48%
PM (TTM) 10.59%
GM 22.1%
OM growth 3Y-25.8%
OM growth 5YN/A
PM growth 3Y-20.54%
PM growth 5YN/A
GM growth 3Y-5.54%
GM growth 5YN/A
RAY Yearly Profit, Operating, Gross MarginsRAY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 2025 5 10 15 20 25

9

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), RAY is creating value.
Compared to 1 year ago, RAY has more shares outstanding
RAY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
RAY Yearly Shares OutstandingRAY Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2025 5M 10M 15M
RAY Yearly Total Debt VS Total AssetsRAY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2025 20M 40M 60M 80M

2.2 Solvency

RAY has an Altman-Z score of 9.35. This indicates that RAY is financially healthy and has little risk of bankruptcy at the moment.
RAY has a Altman-Z score of 9.35. This is amongst the best in the industry. RAY outperforms 86.36% of its industry peers.
There is no outstanding debt for RAY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 9.35
ROIC/WACC1.16
WACC10.18%
RAY Yearly LT Debt VS Equity VS FCFRAY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 2025 20M 40M 60M

2.3 Liquidity

RAY has a Current Ratio of 5.29. This indicates that RAY is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of RAY (5.29) is better than 90.91% of its industry peers.
RAY has a Quick Ratio of 5.19. This indicates that RAY is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of RAY (5.19) is better than 90.91% of its industry peers.
Industry RankSector Rank
Current Ratio 5.29
Quick Ratio 5.19
RAY Yearly Current Assets VS Current LiabilitesRAY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2025 20M 40M 60M 80M

3

3. Growth

3.1 Past

RAY shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -25.16%.
RAY shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -4.14% yearly.
RAY shows a strong growth in Revenue. In the last year, the Revenue has grown by 22.00%.
Measured over the past years, RAY shows a very strong growth in Revenue. The Revenue has been growing by 20.41% on average per year.
EPS 1Y (TTM)-25.16%
EPS 3Y-4.14%
EPS 5YN/A
EPS Q2Q%-23.49%
Revenue 1Y (TTM)22%
Revenue growth 3Y20.41%
Revenue growth 5YN/A
Sales Q2Q%17.57%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
RAY Yearly Revenue VS EstimatesRAY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 20M 40M 60M

4

4. Valuation

4.1 Price/Earnings Ratio

RAY is valuated cheaply with a Price/Earnings ratio of 6.33.
Based on the Price/Earnings ratio, RAY is valued cheaper than 95.45% of the companies in the same industry.
When comparing the Price/Earnings ratio of RAY to the average of the S&P500 Index (27.27), we can say RAY is valued rather cheaply.
Industry RankSector Rank
PE 6.33
Fwd PE N/A
RAY Price Earnings VS Forward Price EarningsRAY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

81.82% of the companies in the same industry are more expensive than RAY, based on the Enterprise Value to EBITDA ratio.
The rest of the industry has a similar Price/Free Cash Flow ratio as RAY.
Industry RankSector Rank
P/FCF 31.09
EV/EBITDA 8.45
RAY Per share dataRAY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.1 0.2 0.3

4.3 Compensation for Growth

The decent profitability rating of RAY may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for RAY!.
Industry RankSector Rank
Dividend Yield N/A

RAYTECH HOLDING LTD

NASDAQ:RAY (9/15/2025, 8:00:01 PM)

After market: 0.58 +0.01 (+1.75%)

0.57

+0.03 (+5.95%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryDistributors
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.57%
Inst Owner ChangeN/A
Ins Owners31.19%
Ins Owner ChangeN/A
Market Cap24.85M
AnalystsN/A
Price TargetN/A
Short Float %6.66%
Short Ratio0.37
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 6.33
Fwd PE N/A
P/S 1.59
P/FCF 31.09
P/OCF 31.09
P/B 2.51
P/tB 2.51
EV/EBITDA 8.45
EPS(TTM)0.09
EY15.79%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.02
FCFY3.22%
OCF(TTM)0.02
OCFY3.22%
SpS0.36
BVpS0.23
TBVpS0.23
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 13.62%
ROE 16.79%
ROCE 15.03%
ROIC 11.76%
ROICexc N/A
ROICexgc N/A
OM 9.48%
PM (TTM) 10.59%
GM 22.1%
FCFM 5.1%
ROA(3y)14.95%
ROA(5y)27.53%
ROE(3y)24.16%
ROE(5y)43.37%
ROIC(3y)21%
ROIC(5y)38.94%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)26.84%
ROCE(5y)49.77%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-25.8%
OM growth 5YN/A
PM growth 3Y-20.54%
PM growth 5YN/A
GM growth 3Y-5.54%
GM growth 5YN/A
F-Score4
Asset Turnover1.29
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 53.78%
Profit Quality 48.14%
Current Ratio 5.29
Quick Ratio 5.19
Altman-Z 9.35
F-Score4
WACC10.18%
ROIC/WACC1.16
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)135.97%
Profit Quality(5y)122.72%
High Growth Momentum
Growth
EPS 1Y (TTM)-25.16%
EPS 3Y-4.14%
EPS 5YN/A
EPS Q2Q%-23.49%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)22%
Revenue growth 3Y20.41%
Revenue growth 5YN/A
Sales Q2Q%17.57%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-36.86%
EBIT growth 3Y-10.65%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-60.5%
FCF growth 3Y-8.86%
FCF growth 5YN/A
OCF growth 1Y-60.5%
OCF growth 3Y-8.91%
OCF growth 5YN/A